Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder
NCT ID: NCT01547702
Last Updated: 2014-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
116 participants
INTERVENTIONAL
2012-02-29
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Teacher Help for Children and Youth With Mental Health Disorders
NCT02919215
Implementation Strategy Resource Package for Behavioral Classroom Interventions: Pilot Test
NCT05489081
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
NCT01919073
A+ Treatment/Feasibility of Adapted ESDM-informed Caregiver Coaching Delivered Remotely for Children With ASD (Autism Spectrum Disorder) and ADHD (Attention Deficit Hyperactivity Disorder)
NCT05417607
Impact of Combined Medication and Behavioral Treatment for ASD & ADHD
NCT03242772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most well-researched areas in childhood psychopathology. ADHD is a highly prevalent (5% of school-aged children) and chronic disorder (ADHD will persist into adulthood for \~70% of children diagnosed with this disorder). ADHD has a substantial impact on daily life including difficulties with behavioural, academic, social and emotional functioning (DuPaul \& Weyandt, 2006).
Although medication is the most commonly used treatment, there are a number of important limitations including poor long-term effects, lack of effectiveness in improving academic skills, and lack of acceptability by parents and children (DuPaul, 2007). Therefore, a number of psychosocial interventions have been developed and empirically validated (parent training, social skills training, school-based interventions). School-based interventions have been shown to be effective; however, these are significantly underutilized and when implemented in an uncontrolled way, are often ineffective. This intervention program is comprised of evidence-based treatment strategies that are presented in a manner that will provide teachers with knowledge of the disorder and intervention strategies. The novel delivery of this program, through distance treatment modalities (e-mail and internet) will allow us to overcome many of the known barriers to treatment so that teachers will receive the necessary information in a timely and efficient manner. The specific research questions that will be addressed are:
1. Does the overall impairment of children with ADHD in the treatment group improve compared to those who are in the waitlist group?
2. Is the school-based intervention effective in reducing ADHD symptoms, improving behavioral functioning, and enhancing academic performance in the active treatment group compared to the waitlist group?
3. Do teachers in the treatment group develop more knowledge about ADHD and more positive and realistic attitudes about this disorder over the course of the intervention?
4. Is the intervention viewed as accessible to teachers and is there evidence of fidelity to the program?
The investigators expect that the program will reduce overall impairment, improve ADHD symptoms, behavioural, and academic functioning in the children and will enhance knowledge and reduce misconceptions of ADHD in teachers. If successful, this program will be disseminated to school boards in Nova Scotia and across Canada, and as such would have the potential to have a significant positive effect on the health and well-being of many children, teachers and parents.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
This group will have access to the Teacher Help for ADHD intervention program during the randomized controlled trial.
Teacher Help for ADHD
Teachers will review powerpoints other materials online and will have access to a study coach to assist with their understanding and practical application of the materials. Session descriptions follow:
* Session 1: Provide information about ADHD characteristics, impact, diagnosis, etiology
* Session 2: Help establish teacher's role; goal setting; introduce behaviour planning
* Session 3: Help develop and implement behaviour program specific to the needs of students with Session 2 goals
* Session 4: Help develop strategies re: classroom structure, work assignments, teacher-student relationship
* Session 5: Help to use instructional interventions for ADHD
* Session 6: Help to teach these students self-monitoring and self-evaluation skills; help teachers to evaluate progress, phase out behaviour program, and plan for relapses in unwanted behaviours
Waitlist Control
This group will not receive the intervention until all data collection is complete for their study cohort.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teacher Help for ADHD
Teachers will review powerpoints other materials online and will have access to a study coach to assist with their understanding and practical application of the materials. Session descriptions follow:
* Session 1: Provide information about ADHD characteristics, impact, diagnosis, etiology
* Session 2: Help establish teacher's role; goal setting; introduce behaviour planning
* Session 3: Help develop and implement behaviour program specific to the needs of students with Session 2 goals
* Session 4: Help develop strategies re: classroom structure, work assignments, teacher-student relationship
* Session 5: Help to use instructional interventions for ADHD
* Session 6: Help to teach these students self-monitoring and self-evaluation skills; help teachers to evaluate progress, phase out behaviour program, and plan for relapses in unwanted behaviours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Student has been formally diagnosed with Attention Deficit Hyperactivity Disorder having a diagnosis of ADHD
* Student is either on a stable dose of medication or no medication with no plan to start/change medication in the next 5 months
Exclusion Criteria
* Student is on an Individualized Program Plan (IPP) due to significant physical, behavioural, communication, or learning difficulties.
* Teacher participated in the Teacher Help for ADHD pilot study (conducted by Brittany Barnett, Master of Health Informatics Student under the supervision of Dr. Elik and Dr. Corkum, Dalhousie University)
6 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dalhousie University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Penny V Corkum, PhD
Role: PRINCIPAL_INVESTIGATOR
Dalhousie University
Nezihe Elik, PhD
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dalhousie University
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSHRF-44576
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.